{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:52:20Z","timestamp":1785214340141,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.antiviral.2007.03.006","type":"journal-article","created":{"date-parts":[[2007,4,5]],"date-time":"2007-04-05T11:11:57Z","timestamp":1175771517000},"page":"210-218","source":"Crossref","is-referenced-by-count":21,"title":["Molecular basis of antagonism between K70E and K65R tenofovir-associated mutations in HIV-1 reverse transcriptase"],"prefix":"10.1016","volume":"75","author":[{"given":"R.M.","family":"Kagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.-S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"R.M.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Lewinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.","family":"Potts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2007.03.006_bib1","series-title":"Computer Simulation of Liquids","author":"Allen","year":"1987"},{"key":"10.1016\/j.antiviral.2007.03.006_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jcc.540040211","article-title":"CHARMM: a program for macromolecular energy, minimisation and dynamics calculations","volume":"4","author":"Brooks","year":"1983","journal-title":"Comput. Chem."},{"key":"10.1016\/j.antiviral.2007.03.006_bib3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/bip.360240509","article-title":"Active site dynamics in protein molecules: a stochastic boundary molecular-dynamics approach","volume":"24","author":"Brooks","year":"1985","journal-title":"Biopolymers"},{"key":"10.1016\/j.antiviral.2007.03.006_bib4","first-page":"S134","article-title":"Rise and fall of the RT K65R incidence in the Portuguese resistance database","volume":"11","author":"Camacho","year":"2006","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2007.03.006_bib5","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1128\/AAC.40.9.2212","article-title":"Novel mutation (K70E) in human immunodeficiency virus type 1 reverse transcriptase confers decreased susceptibility to 9-[2-(phosphonomethoxy)ethyl]adenine in vitro","volume":"40","author":"Cherrington","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.03.006_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jcv.2004.05.020","article-title":"Selection of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DF","volume":"32","author":"Delaugerre","year":"2005","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2007.03.006_bib7","doi-asserted-by":"crossref","first-page":"42097","DOI":"10.1074\/jbc.M206725200","article-title":"The molecular mechanism of multidrug resistance by the Q151M human immunodeficiency virus type 1 reverse transcriptase and its suppression using alpha-boranophosphate nucleotide analogues","volume":"277","author":"Deval","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2007.03.006_bib8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1074\/jbc.M308806200","article-title":"Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations","volume":"279","author":"Deval","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2007.03.006_bib9","first-page":"S91","article-title":"Changes in prevalence of NRTI resistance associated mutations among clinical isolates from 1999\u20132003","volume":"9","author":"Faruki","year":"2004","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2007.03.006_bib10","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1086\/498069","article-title":"Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects","volume":"192","author":"Gallant","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.03.006_bib11","doi-asserted-by":"crossref","first-page":"33624","DOI":"10.1074\/jbc.273.50.33624","article-title":"Functional analysis of amino acid residues constituting the dNTP binding pocket of HIV-1 reverse transcriptase","volume":"273","author":"Harris","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2007.03.006_bib12","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1126\/science.282.5394.1669","article-title":"Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance","volume":"282","author":"Huang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2007.03.006_bib13","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.1073\/pnas.90.13.6320","article-title":"Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA","volume":"90","author":"Jacobo-Molina","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2007.03.006_bib14","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.antiviral.2007.03.006_bib15","first-page":"S103","article-title":"Adefovir-associated HIV-1 RT mutation K70E in the age of tenofovir","volume":"10","author":"Kagan","year":"2005","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2007.03.006_bib16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/135965350400900519","article-title":"Increasing prevalence of HIV-1 reverse transcriptase mutation K65R correlates with tenofovir utilization","volume":"9","author":"Kagan","year":"2004","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2007.03.006_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/apc.2005.19.135","article-title":"Early virologic failure in a pilot study evaluating the efficacy of therapy containing once-daily abacavir, lamivudine, and tenofovir DF in treatment-naive HIV-infected patients","volume":"19","author":"Khanlou","year":"2005","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.antiviral.2007.03.006_bib18","doi-asserted-by":"crossref","first-page":"10292","DOI":"10.1021\/bi970512z","article-title":"Single-step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC","volume":"36","author":"Krebs","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2007.03.006_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1310\/9DQP-R7JA-75ED-RBCP","article-title":"Early virologic failure and rescue therapy of tenofovir, abacavir, and lamivudine for initial treatment of HIV-1 infection: TONUS study","volume":"6","author":"Landman","year":"2005","journal-title":"HIV Clin. Trials"},{"key":"10.1016\/j.antiviral.2007.03.006_bib20","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/01.aids.0000186821.30489.16","article-title":"High rate of virological failure in maintenance antiretroviral therapy with didanosine and tenofovir","volume":"19","author":"Leon","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2007.03.006_bib21","series-title":"45th Interscience Conference on Antimicrobial Agents and Chemotherapy","article-title":"HIV-1 RT mutations K70E and K65R are not present on the same viral genome when both mutations are detected in plasma","author":"Lloyd","year":"2005"},{"key":"10.1016\/j.antiviral.2007.03.006_bib22","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/01.aids.0000176218.40861.14","article-title":"Early virologic failure in HIV-1 infected subjects on didanosine\/tenofovir\/efavirenz: 12-week results from a randomized trial","volume":"19","author":"Maitland","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2007.03.006_bib23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00042560-200108150-00005","article-title":"Adefovir and tenofovir susceptibilities of HIV-1 after 24 to 48 weeks of adefovir dipivoxil therapy: genotypic and phenotypic analyses of study GS-96-408","volume":"27","author":"Miller","year":"2001","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.antiviral.2007.03.006_bib24","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1128\/JVI.80.10.4971-4977.2006","article-title":"The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations","volume":"80","author":"Parikh","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.03.006_bib25","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1128\/AAC.49.3.1139-1144.2005","article-title":"In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase","volume":"49","author":"Parikh","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.03.006_bib26","first-page":"S102","article-title":"Selection of the HIV-1 reverse transcriptase mutation K70E in antiretroviral-naive subjects treated with tenfovir\/abacavir\/lamivudine therapy","volume":"10","author":"Ross","year":"2005","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2007.03.006_bib27","series-title":"12th Conference on Retroviruses and Opportunistic Infections","article-title":"Clonal analysis of week 12 virologic non-responders receiving tenofovir\/abacavir\/lamivudine in ESS30009","author":"Rouse","year":"2005"},{"key":"10.1016\/j.antiviral.2007.03.006_bib28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","article-title":"Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes","volume":"23","author":"Ryckaert","year":"1977","journal-title":"J. Comp. Phys."},{"key":"10.1016\/j.antiviral.2007.03.006_bib29","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1016\/S1074-5521(99)80071-4","article-title":"Touching the heart of HIV-1 drug resistance: the fingers close down on the dNTP at the polymerase active site","volume":"6","author":"Sarafianos","year":"1999","journal-title":"Chem. Biol."},{"key":"10.1016\/j.antiviral.2007.03.006_bib30","doi-asserted-by":"crossref","first-page":"48466","DOI":"10.1074\/jbc.M107003200","article-title":"Mechanism-based suppression of dideoxynucleotide resistance by K65R human immunodeficiency virus reverse transcriptase using an alpha-boranophosphate nucleoside analogue","volume":"276","author":"Selmi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2007.03.006_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.virol.2003.11.013","article-title":"Replication-dependent 65R\u2013>K reversion in human immunodeficiency virus type 1 reverse transcriptase double mutant K65R+L74V","volume":"321","author":"Sharma","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2007.03.006_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/AAC.00683-06","article-title":"Molecular mechanism by which the K70E mutation in human immunodeficiency virus type 1 reverse transcriptase confers resistance to nucleoside reverse transcriptase inhibitors","volume":"51","author":"Sluis-Cremer","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.03.006_bib33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/135965350501000405","article-title":"Early virological failure after tenofovir+didanosine+efavirenz combination in HIV-positive patients upon starting antiretroviral therapy","volume":"10","author":"Torti","year":"2005","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2007.03.006_bib34","first-page":"S144","article-title":"Sensitivity of Phenotypic Analyses for detection of low levels of K65R, M184V, or K65R\/M184V in mixtures with wild-type HIV-1","volume":"9","author":"Underwood","year":"2004","journal-title":"Antiviral Therapy"},{"key":"10.1016\/j.antiviral.2007.03.006_bib35","first-page":"S160","article-title":"NRTI resistance associated with the RT mutation K70E in HIV-1","volume":"11","author":"Van Houtte","year":"2006","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2007.03.006_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/135965359900400205","article-title":"In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA","volume":"4","author":"Wainberg","year":"1999","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2007.03.006_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/135965350601100209","article-title":"The K65R reverse transcriptase mutation in HIV-1 reverses the excision phenotype of zidovudine resistance mutations","volume":"11","author":"White","year":"2006","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2007.03.006_bib38","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/AAC.48.3.992-1003.2004","article-title":"Molecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69 and multiple thymidine analog-associated mutations","volume":"48","author":"White","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.03.006_bib39","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/AAC.46.11.3437-3446.2002","article-title":"Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity","volume":"46","author":"White","year":"2002","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354207002574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354207002574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T09:50:06Z","timestamp":1683798606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354207002574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0166354207002574"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2007.03.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}